Hexagon Nutrition IPO Details

Founded in 1993, Hexagon Nutrition Limited is a research-led nutrition company engaged in the development and manufacturing of micronutrient premixes, clinical and wellness nutrition products, therapeutic formulations, and ready-to-use nutritional solutions. Over the years, the company has evolved into an integrated nutrition platform with capabilities spanning product research, formulation development, manufacturing, quality assurance, and global distribution.

The company operates four manufacturing facilities, including three units in India located at Nashik, Chennai, and Thoothukudi, along with an international facility in Tashkent, Uzbekistan. The Chennai and Thoothukudi plants are situated in Special Economic Zones (SEZs), offering logistical efficiencies, proximity to ports, and duty-free import benefits for export-oriented operations.

Hexagon Nutrition’s business is broadly divided into three key segments. Its B2C segment includes branded wellness and clinical nutrition products marketed under brands such as PENTASURE, OBESIGO, PEDIAGOLD, and NUTRONE. The B2B2C segment focuses on customized vitamin and mineral premixes supplied to leading FMCG and food companies for food fortification initiatives. The ESG-focused segment includes Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs), which are supplied for global nutrition and malnutrition programs supported by international health organizations and UN-led initiatives.

The company has established a strong omnichannel distribution network across India, covering retail pharmacies, hospital networks, online marketplaces, e-commerce platforms, and its own branded websites. It works with more than 342 distributors nationwide, including several with multi-state operations, strengthening its domestic market reach.

Internationally, Hexagon Nutrition has built a growing presence through offices in South Africa, Uzbekistan, and Hong Kong. Between FY2023 and FY2025, the company exported products to over 75 countries across Asia, Africa, Europe, the Middle East, and Latin America, with exports contributing more than 61% of total revenue in FY25.

In FY25, the company reported revenue of INR 324.9 crore, compared to INR 278.5 crore in FY23. Premix formulations contributed 47.6% of total revenue, while branded nutrition and therapeutic nutrition accounted for 28.3% and 24.0%, respectively.

Hexagon Nutrition also maintains dedicated in-house R&D facilities at Nashik and Chennai, supported by a team of qualified professionals focused on product innovation, quality enhancement, and regulatory compliance. Its manufacturing operations are backed by certifications including FSSC 22000, GMP, ISO 9001:2015, and Halal certifications, reflecting its focus on global quality standards. As of July 31, 2025, the company employed 482 people across its operations.